Melisi, Davide http://orcid.org/0000-0002-4031-7585
Garcia-Carbonero, Rocio
Macarulla, Teresa
Pezet, Denis
Deplanque, Gael
Fuchs, Martin
Trojan, Jorg
Kozloff, Mark
Simionato, Francesca
Cleverly, Ann
Smith, Claire
Wang, Shuaicheng
Man, Michael
Driscoll, Kyla E.
Estrem, Shawn T.
Lahn, Michael M. F.
Benhadji, Karim A.
Tabernero, Josep
Funding for this research was provided by:
Eli Lilly and Company (230-0061-07472)
Article History
Received: 22 October 2018
Accepted: 1 March 2019
First Online: 18 March 2019
Compliance with ethical standards
:
: Ann Cleverly, Ivelina Gueorguieva, Karim A. Benhadji, Shawn T. Estrem, Kyla Driscoll, and Michael Man are employees of Eli Lilly and Company, Indianapolis, Indiana, USA, and may hold company stock. Michael M. F. Lahn and Claire Smith are former employees of Eli Lilly and Company and hold company stock. Josep Tabernero has had an advisory role for Bayer, Boehringer Ingelheim, Genentech/Roche, Lilly, MSD, Merck Serono, Merrimack, Novartis, Peptomyc, Roche, Sanofi, Symphogen, and Taiho. Denis Pezet has had an advisory role for Sanofi, Novartis, and Roche.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.